StopUMTS Logo
how to get rid of moles
Zoeken
   
Voorlichting
20/03/17Meetspecialisten, meet
16/03/17Plaatsing zendmasten en g
Artikelen
25/03/17De slimme meter als spion
24/03/17Video over de gevaren van
24/03/17Voordracht Hugo Schooneve
23/03/17COMPILATIE: Maatregelen v
23/03/17Google Glass Alert: Po
20/03/17Profitability Versus Publ
Berichten Nederland
28/03/17Overijssel: Leegstaande b
27/03/17Bilthoven: Hoorzitting ze
26/03/17‘12.000 doden, we moete
26/03/17Maurice de Hond stapt noo
22/03/17SOLK: bericht op facebook
Berichten België
18/03/17Proximus lanceert 4,5G in
09/02/17Lezing: Elektrosmog - De
Berichten Internationaal
23/03/17USA: Massachusetts Cel
23/03/17USA: Seventeen Ohio Ci
23/03/17Filipijnen: Community res
22/03/17Bangladesh: A mobile t
Ervaringen | Appellen/oproepen
28/03/17Met vacantie; ervaringsve
19/03/17Hong Kong residents urge
06/03/17Mother Warns Women Not to
Onderzoeken
24/03/17Combined biological and h
20/03/17High radiofrequency radia
20/03/17Evaluation of Mobile P
Veel gestelde vragen
23/07/16Vakantie? Witte zo
10/07/16Zeven veel gestelde vrage
Juridische informatie
05/03/17'Staat moet verantwoordel
28/02/17USA: Judge Rules Californ
28/01/17Oostenrijk: Een burgemees
Oproepen
22/04/17Stichting EHS: Landelijke
08/04/17CURSUS: Straling meten
27/03/17Lezing over Kanker in Haa
Folders
21/02/17Brochures, folders, websi
29/04/16USA: Meer dan 50 tips voo
Briefwisselingen | Archief: 2008, 2005
05/03/17Mail naar ''kunnenweprate
05/03/17Brief aan de gemeente Epe
Illustraties
 Algemeen
 Fotoalbum zendmasten
 Wetenschappelijke illustraties
Should journals stop publishing research funded by the industry?    
Ga naar overzicht berichten in: Berichten Internationaal

Should journals stop publishing research funded by the industry?
woensdag, 15 januari 2014 - Dossier: Internationale berichten


Should journals stop publishing research funded by the drug industry?
Bron: www.bmj.com/content/348/bmj.g171 .
14 jan. 2014


BMJ 2014; 348 doi: dx.doi.org/10.1136/bmj.g171 (Published 14 January 2014)
Cite this as: BMJ 2014;348:g171

The BMJ no longer publishes research funded by tobacco companies. Richard Smith and Peter Gøtzsche say that research funded by drug companies is also flawed and published to encourage sales, but Trish Groves says that the industries are fundamentally different and that moves are afoot to increase integrity

Yes— Richard Smith and Peter C Gøtzsche
The BMJ and its sibling journals have stopped publishing research funded by the tobacco industry for two main reasons: the research is corrupted and the companies publish their research to advance their commercial aims, oblivious of the harm they do.1 But these arguments apply even more strongly to research funded by the drug industry, and we suggest there is a better way to communicate the results of trials that would be safer for patients.

Prescribed drugs are the third leading cause of death, partly because of flaws in the evidence published in journals. We have long known that clinical trials funded by the drug industry are much more likely than publicly funded trials to produce results favourable to the company.2 The reason is obvious. The difference between an honest and a less than honest data analysis can be worth billions of euros, and the fraudulent trials of some cyclo-oxygenase-2 inhibitors for arthritis and selective serotonin reuptake inhibitors for depression are good examples.3 4 5

Industry cannot be trusted
There are many clever ways in which companies manipulate their research,6 and two recently published books give dozens of examples.3 7 Flaws in the coding of adverse events can distort results without leaving any trace of what has happened, as we cannot get access to the raw data the drug companies hold. Three large trials of prasugrel, rosiglitazone, and ticagrelor made by Daiichi Sankyo and Eli Lilly, GlaxoSmithKline, and AstraZeneca, respectively, published in the New England Journal of Medicine were shown to be …

Een geweldig besluit van het BMJ, dit besluit om niet te publiceren zou ditect toegepast kunnen worden op door de Telecomindustrie gefinancierd onderzoek naar de biologische, mogelijk schadelijke, effecten van EMV voor de gezondheid..


Ga terug naar het hoofdmenu
Afdrukken | Vragen | RSS | Disclaimer